Seeking Alpha

Neoprobe (NEOP +4.8%) shares are higher today after submitting a new drug application to the FDA...

Neoprobe (NEOP +4.8%) shares are higher today after submitting a new drug application to the FDA for its cancer detection platform Lymphoseek. The company seeks clearance to market it for use in surgical oncology procedures.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs